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CalciﬁcationsAbstract Objective: To evaluate the impact of adding 3D Tomosynthesis to Full Field Digital
Mammography (FFDM) in the detection and diagnosis of breast lesions.
Subjects and methods: The study included 166 mammograms with indeterminate ﬁndings selected
from 1600 mammograms. They were classiﬁed into two groups: group 1 ‘Diagnostic mammograms’
of symptomatic women and group 2 ‘Screening mammograms’. Dense breasts assigned as ACR3 and
ACR4 presented 69% (n= 114/166) of the studied cases. FFDMand 3D tomosynthesis examination
was done and imaging ﬁndings were evaluated before and after the use of 3D tomosynthesis
images.
Results: Both modalities were compared regarding detection and diagnosis, each individually
assessed, using the Pearson Chi Square tests. Detection (P value: 0.006) and diagnosis (P value:
0.048) of breast lesions dramatically improved when 3D tomosynthesis images were considered in
the evaluation. The sensitivity, speciﬁcity, and accuracy of digital mammography was 60%,
20.7% and 48% have signiﬁcantly enhanced on applying tomosynthesis to be 94.5%, 74% and
89.7%.
Conclusion: Three-dimensional tomosynthesis signiﬁcantly enhanced the detection and character-
ization of breast lesions on digital mammography especially in the context of dense breast paren-
chyma (ACR 3&4).
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.
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Mammography is an effective imaging tool for the detection of
early-stage breast cancer, and it is the only screening modality
proved to reduce mortality from breast cancer (1–3). However,
the appearance of overlapping tissue on mammograms poses a
signiﬁcant obstacle to interpretation (4–7).
Breast tomosynthesis is anew tool that canbe expected toame-
liorate this problem by reducing or eliminating tissue overlap (8).
The purpose of this study is to evaluate the potential impact
of adding 3D Tomosynthesis to Full Field Digital Mammogra-
phy on the detection and diagnosis of breast lesions.
2. Material and methods
This study is a prospective analysis approved by the Ethics
Committee inWadi El-Neel Hospital, where radiological exam-
ination of the study cases had been performed in a well
equipped and organized breast imaging unit incorporation with
Institute Gustave-Roussy (IGR), the leading European anti-
cancer center. Included cases have given informed consents.
2.1. Material
The study included 166 consecutive mammograms with posi-
tive ﬁndings on the standard mammography examination.
Studies were performed during the period of 13 months.
Included cases were classiﬁed into two groups according to
the objective of their referral: Group 1: ‘Diagnostic mammo-
grams’ of symptomatic women. Group 2: ‘Screening mammo-




A combined FFDM and 3D tomosynthesis examination was
done by Hologic Selenia Dimensions Digital Tomosynthesis
System using the following steps:
 Position views: Images are taken both in the cranio-caudal
(CC) and medio-lateral oblique (MLO) views.
 Acquisition: The system attains a ‘‘Combo-mode’’ imaging
technique (2D + 3D imaging) that acquires a traditional
digital mammogram and a tomosynthesis scan in the same
compression. During a tomosynthesis scan, multiple (11–
15), low-dose images of the breast are acquired at different
angles while the X-ray tube moves in an arc across the
breast. These images are then used to produce a series of
one-millimeter thick images (from 60 to 90 slices) that can
be reconstructed to a three dimensional image of the breast.
 Displaymethodology: Images are displayed on dedicated high
resolution workstations with special capabilities that are tai-
lored for breast imaging. The re-constructed tomosynthesis
images can be viewed as one slice at a time or in a cine loop.
2.2.2. Ultrasound examination
A complementary ultrasound examination was performed for
all cases using both B-mode and elastography ultrasound onAplio XG device (Toshiba, Japan) to conﬁrm or exclude mam-
mography identiﬁed abnormalities. Examination was done by
6–9 MHz high frequency probes.
2.3. Image analysis
According to the ‘‘Breast Imaging Data and Reporting
System’’ (9) mammograms of all patients were assigned an ini-
tial BIRADS category in view of their Full Field Digital mam-
mography (FFDM) ﬁndings by two independent readers (A.L.
and M.S. of 18 and 15 years experience) into: (i) BIRADS 3 or
BIRADS 4 mammograms: with indeterminate benign or
malignant mammography ﬁndings, (ii) BIRADS 1 and BIR-
ADS 2 mammograms: if the tomosynthesis images added
new undetected lesions in BIRADS 1 or changed the category
of detected ones in BIRADS 2 and (iii) BIRADS 5 cases: when
additional ﬁndings were reported on reviewing the tomosyn-
thesis images (e.g. additional undetected lesions or wider
tumor extent).
A second look of the mammograms established by another
individual reader (M.O. of 20 years experience) and another
BIRADS category assigned after a combined review of both
the tomosynthesis and the regular digital mammography
images.
The authors were blinded regarding the image analysis per-
formed by each of them and both the initial mammogram
(only regular mammogram) and re-evaluation (combined
tomosynthesis and regular mammography images) were per-
formed without knowledge of the pathology results. At the
stage of ﬁnal evaluation, there was multidisciplinary discussion
of ﬁndings with the authors and the breast surgery consultant
(O.O.).
On reporting the mammogram, we answered the following
questions before and after evaluating the 3D tomosynthesis
images:
1. Can we detect any abnormality? (mass lesions, parenchymal
distortion, focal asymmetries, micro calciﬁcations or diffuse
breast edema pattern).
2. Can we characterize/ diagnose this abnormality? (i.e. classify
as benign, indeterminate or malignant).
3. Which BIRADS category could we assign?
4. Should we recommend or deter further biopsy?
5. Does the FFDM ﬁndings whether or not combined with 3D
tomosynthesis concomitant with the pathology results?
6. Do we need a follow up study for conﬁrming the current
mammography ﬁndings?
Ultrasound guided core biopsy using a 14G biopsy needle
was performed in 63% (n= 104) for malignant looking (BI-
RADS 5), suspicious (BI-RADS 4) and indeterminate lesions
(BI-RADS 3). The remaining BI-RADS 3 category (n= 26)
and BI-RADS 2 category (n= 35) lesions were managed
according to the ACR guideline which is determined during
the follow up: a one year stable lesion was considered of
benign nature.
2.4. Statistical analysis
Imaging ﬁndings were tabulated and categorical results of Full
Field Digital Mammography and 3D Digital Tomosynthesis
Fig. 1 Tiny carcinoma that could be only identiﬁed on the tomosynthesis images (circle in B).
Impact of three dimensional tomosynthesis 1055were included. Both modalities were compared in the context
of detection and diagnosis, each was individually assessed,
using the Pearson Chi Square tests. The sensitivity, speciﬁcity,
accuracy and positive and negative predictive values of either
modality were also calculated. P value <0.05 is considered
to be signiﬁcant.
3. Results
The study included two groups of patients. Group 1 patients
(94 cases, 56.4%) were symptomatic cases. Group 2 patients
(72 cases, 43%) were asymptomatic ones coming for their reg-
ular annual check-up (Fig. 1).
Increased breast density signiﬁcantly affected the diagnostic
ability of mammography. Such cases were misinterpreted in
mammograms and were assigned with breast densities of
ACR3 (48.2%, n= 80/166), and ACR4 (20.5%, n= 34/166).
The capability of FFDM and 3D tomosynthesis in the
detection of breast pathologies was simpliﬁed in Table 1.
Tomosynthesis signiﬁcantly enhanced the detection of the
breast lesions on mammography images especially in the con-
text of dense breast parenchyma (P value: 0.006) (Fig. 2). The
detection of multicentric lesions was also accessible in the
tomosynthesis images (Fig. 3).
Using of tomosynthesis slices also signiﬁcantly helped in
better lesions characterization and consequently veriﬁed
benign or malignant impression of the identiﬁed masses (P
value: 0.048) (Table 2, Fig. 4). Based on tomosynthesis images,
tumor margins were better assessed (n= 101). Also clusters of
microcalciﬁcations (n= 66) were better identiﬁed (Fig. 4b)
especially in dense breasts.Table 1 Comparison between the detection capability of
FFDM before and after 3D tomosynthesis imaging application
in the assessment of breast lesions.
Mammography detection Tomosynthesis detection Total
Yes No
Yes 125 (75.3%) 3 (1.8%) 128 (77.1%)
No 33 (19.9%) 5 (3.0%) 38 (22.9%)
Total 158 (95.2%) 8 (4.8%) 166 (100%)All mammograms were assigned an initial BI-RADS cate-
gory, then the 3D tomosynthesis images were re-viewed and
the BIRADS score was re-adjusted by being either upgraded,
downgraded or remained unchanged (Table 3).
Adding the 3D tomosynthesis images to the regular mam-
mography signiﬁcantly enhanced accurate BIRADS scoring
(P value: 0.00). In reference to Table 3 we can deduce the
following:
 Three-dimensional tomosynthesis images signiﬁcantly
decreased the number of indeterminate/suspicious lesions,
(BIRADS 3 & 4) by either supporting a benign (downgrad-
ing) or a malignant (upgrading) diagnosis.
 In BI-RADS 5 (28.9%, n= 48) cases, 3D tomosynthesis
showed more accurate tumor extension and allowed better
prediction of subtle microcalciﬁc clusters especially in dense
breast parenchyma (Fig. 5).
 Pathologically proved BIRADS 6 lesions (3%, n= 5) that
were under neoadjuvant chemotherapy could not be identi-
ﬁed on mammography. Tomosynthesis allowed better
depiction of such pathologies by providing the possibility
of recognizing post therapy residual tumor tissue (Fig. 6).
 Tomosynthesis did not only allow a more conﬁdent malig-
nant diagnosis of some mass lesions but it helped in con-
ﬁrming the benign nature of BIRADS 2 (31.3%, n= 52)
lesions as well. The presence of well deﬁned margins, the
typical benign radiolucent halo and the intra-lesional fat
density veriﬁed the benign diagnosis of these lesions.
 Operative bed recurrence could be excluded from extensive
scars (4.8%, n= 8). In such cases, no recurrent masses were
identiﬁed in any of the tomosynthesis slices and moreover in
ﬁve cases, associated central fat density could be elicited
which further excluded tumor recurrence (Fig. 7).
Recommendation of biopsy for detected lesions was based
on the combined evaluation of FFDM, 3D tomosynthesis
and ultrasound examinations (Table 4). Revision of pathology
specimens revealed 77 malignant lesions (46.4%) and 89
benign lesions (53.6%). Ten cases (6%) of those benign lesions
were found to be precancerous. With the aid of tomosynthesis
slices, 62 cases (37.3%) were saved from unnecessary biopsy.
The sensitivity, speciﬁcity, and positive and negative predic-
tive values of FFDM when assessed individually and when
combined with 3D tomosynthesis were illustrated in Table 5.
Fig. 2 Left breast large invasive duct carcinoma that is hardly seen on the FFDM images (A). It was assigned as BIRADS 4. The
carcinoma appears more evident on the tomosynthesis slice (B) and was upgraded to BIRADS 5. Complementary ultrasound (C)
conﬁrmed the tomosynthesis ﬁndings.
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breast lesions in heterogeneous breast parenchyma and one
case of duct carcinoma in situ (DCIS) in an ACR4 breast.
False positive results included two cases of granulomatous
mastitis, four benign precancerous lesions, one case of
post operative fat necrosis and three cases with atypical
ﬁbroadenomas.
4. Discussion
Breast tomosynthesis is considered one of the most challenging
and promising up to date mammography technologies. Tomo-
synthesis is expected to resolve mammography drawbacks by
eliminating tissue overlap due to its ability to acquire 3D
images of the breast (8).
A number of investigators believe that 3D tomosynthesis
has a potential impact in both screening and diagnosticsettings. The use of tomosynthesis could alter the diagnostic
protocol substantially (10).
Several studies had considered breast tomosynthesis an
entrance for a 3D imaging capability that allows more accurate
evaluation of lesions by enabling better differentiation between
overlapping tissues (8,11–14). Most of the articles reviewed its
role literally. There was a paucity of references that had dis-
cussed its use in routine clinical practice.
A prospective study (12), examined the effect on radiogra-
phers’ and radiologists’ workload when implementing 3D
mammography in screening by comparing image acquisition
time and screen-reading time for 2D mammography with that
of combined 2D+ 3D mammography.
The main issue of their study focused upon time consumed
versus accuracy in interpretation of the mammograms of the
selected cases. They found out that combined 2D + 3D mam-
mography prolongs image acquisition time and screen-reading
Fig. 3 Screening mammogram showed a subtle mid upper breast area of parenchymal distortion that became more apparent on one of
the tomosynthesis slices in addition to another lesion (arrows). Complementary ultrasound proved the presence of an underlying two tiny
spiculated mass lesions.
Table 2 Comparison between the diagnostic ability of FFDM
before and after combining the 3D tomosynthesis imaging in
the assessment of breast lesions.
Mammography diagnosis Tomosynthesis diagnosis Total
Yes No
Yes 51 (30.7%) 4 (2.4%) 55 (33.1%)
No 90 (54.2%) 21 (12.7%) 111 (66.9%)
Total 141 (84.9%) 25 (15.1%) 166 (100%)
Impact of three dimensional tomosynthesis 1057time (at initial implementation), yet appears to be associated
with improved screening accuracy, which consequently help
in detection of more cancers (12).
Skaane et al. compared digital mammography and digital
breast tomosynthesis (DBT) in a side-by-side feature analysis
for cancer conspicuity, and assessed whether there is a poten-
tial additional value of DBT to standard conventional imaging
regarding the detection of additional malignancies. The study
included 129 women and actually biopsied 45 breasts (the
remaining 84 cases were dismissed with a normal/deﬁnitely
benign ﬁnding that presented no need for biopsy). According
to their work; the side-by-side feature analysis showed higher
conspicuity scores for tomosynthesis compared to conven-
tional 2D for cancers presenting as spiculated masses and dis-
tortions (15).
Hakim et al. (10) subjectively compared additional mam-
mographic views to DBT when characterizing known masses,
architectural distortions, or asymmetries. The study considered
mammography of 25 women with known masses. After review
of the examinations, radiologists rated their relative preference
in terms of classifying the ﬁnding in question twice; one time
when aided by the additional views and another when aided
by DBT. The diagnostic BI-RADS rating of both examina-
tions was correlated. They found that FFDM and DBT
(combined) were perceived to be better for diagnosis in 50%
of cases. Finally they concluded that DBT may be an alterna-
tive to obtaining additional mammographic views in mostcases especially if the presentation of the concerned lesion is
not by calciﬁcation.
During our experience; the 3D tomosynthesis images had
increased the sensitivity and accuracy of mammography and
signiﬁcantly enhanced accurate BIRADS scoring (P value:
0.00). The proved malignant lesions (n= 77) were correctly
diagnosed by mammography in 14 cases (18.1%), such estima-
tion became more accurate when 3D tomosynthesis included in
the evaluation to be 48 cases (62.3%). Even when malignant
mass lesions were identiﬁed on mammograms, 3D tomosyn-
thesis still has a role in deﬁning actual tumor size and exten-
sion (Fig. 5). We have to admit that the diagnostic accuracy
percentage for FFDM was very low to be accepted on a stan-
dard basis; yet it is a unique situation in this study as most of
the malignant cases were of dense breast categories.
Tomosynthesis signiﬁcantly enhanced the cancer detection
rate of mammography as it showed a sensitivity of 94.5% com-
pared to only 60% in solo mammography evaluation. This was
coupled with its impact on the diagnostic accuracy of mam-
mography that had upgraded from 48% to 89.7%. Improved
depiction of clustered microcalciﬁcations, together with better
margin delineation and superior resolution has paved way for
making an accurate diagnosis (Fig. 4b).
In a study done in 2012, DBT was compared with mammo-
graphic spot views (MSVs) in characterizing 67 breast masses
as benign (n= 37) or malignant (n= 30). In this small-sample
study, mass characterization in terms of visibility ratings,
reader performance, and BI-RADS assessment with DBT
was similar to that with MSVs. Preliminary ﬁndings suggest
that MSV might not be necessary for mass characterization
when performing DBT (16).
From our point of view, tomosynthesis being a ‘‘slice fold-
ing’’ technique has only the capability to locate the site of cal-
ciﬁc clusters but not to accurately suggest the possible
pathology of clusters. Regarding this issue spot magniﬁcation
view is a better method of evaluation.
Kontos et al. in 2011 presented a correlation between the
parenchymal texture features at DBT and digital mammogra-
phy with breast percent density (PD) in a screening population
Fig. 4 Two different cases showing diffuse non speciﬁc edema
pattern of the right breast with coarsened trabeculae, increased
breast density and diffuse skin thickening. Case1 (A) is granu-
lomatous mastitis. Tomosynthesis images added no information.
Case 2 (B) is an extensive invasive duct carcinoma. Malignant
microcalciﬁc clusters and spiculations are excellently demon-
strated on the tomosynthesis image.
Table 3 Comparison between the initial mammography BI-RAD
tomosynthesis images.
Mammography BI-RADS Tomosynthesis BI-RADS
1 2 3
1 4 14 3
2 3 11 1
3 9 22 9
4 2 5 2
5 0 0 0
6 0 0 0
Total 18 52 1
Fig. 5 A typical carcinoma that is easily identiﬁed on the CC
view of a FFDM examination, yet, wider extension could be
depicted on the tomosynthesis slice.
1058 S. Mansour et al.of women. According to their study, parenchymal texture fea-
tures are more strongly correlated to breast PD in DBT than in
digital mammography. The authors’ long-term hypothesis is
that parenchymal texture analysis with DBT will result in
quantitative imaging biomarkers that can improve the estima-
tion of breast cancer risk (17).
The current work included 114 (69%) cases with dense
parenchymal texture (i.e. ACR 3 and 4). Lesions in dense
breast parenchyma were sometimes upgraded or downgraded
on the tomosynthesis images; a fact which had a major impact
in the perspective of recall rates in screening mammography
and in the perspective of biopsy referral in the diagnostic con-
text. It allowed a more conﬁdent diagnosis of both benign and
malignant pathologies.
Breast abnormalities were more depicted at 3D-tomosyn-
thesis that detected 158 out of the 166 studied lesions
(95.2%) and missed only eight lesions (4.8%), while on the
other side digital mammography had missed 38 lesions
(22.9%). Also the interpretation of the abnormality was better
deﬁned by tomosynthesis which characterized and properly
diagnosed 141 lesions (84.9%) while digital mammography
hit the target in only 55 lesions (33.1%).S scoring and the re-adjusted score after re-viewing the 3D
Total
4 5 6
1 0 0 22
5 2 0 22
4 3 0 47
18 29 0 56
0 14 0 14
0 0 5 5
5 28 48 5 166
Fig. 6 Proved carcinoma under neo-adjuvant chemotherapy. Tumor is in-apparent on FFDM image (A). It becomes clearly illustrated
on the tomosynthesis images (arrow in B).
Fig. 7 A 37-year-old female with history of right conservative
breast surgery. She recently noticed a palpable operative bed
lump. Her mammogram showed operative bed microcalciﬁcations
and spiculations. She was assigned BI-RADS 4 score with
suspicious recurrence. Tomosynthesis images showed a central
radio-lucency with ﬁne egg shell calciﬁcations; a picture that is
typical for operative bed fat necrosis. She was downgraded to BI-
RADS 2 score.
Table 4 Number of performed breast biopsies and results of







Benign 79 (47.6%) 17 62
Fibroadenomas 5 1
Mammary dysplasia 2 –





Precancerous 10 (6%) 10 –




Invasive duct carcinoma 67
Total 166 104 62
Table 5 Calculated sensitivity, speciﬁcity, accuracy, and
positive and negative predictive values of FFDM before and
after combining the 3D tomosynthesis in the assessment of
breast lesions.




Positive predictive value 62 92
Negative predictive value 20 80
Impact of three dimensional tomosynthesis 1059Nevertheless we have to admit that breast tomosynthesis
sometimes does not save the case, it holds the challenge of
‘‘absence of mass effect’’. Lesions with no associate architec-
tural compression and/or distortion may be indiscernible from
the related parenchyma in breast with ACR 3&4 categories
(Fig. 8). Such condition may present with a number of consid-
ered pathologies such as: Intraductal epithelial hyperplasia,
lobular carcinoma in situ and ductal carcinoma in situ (DCIS).
Presence of an area of abnormal echo pattern on complemen-
tary breast US could draw attention to biopsy and conse-
quently solve such problem.Bernardi et al. (12), in 2012 stated that there is limited evi-
dence on the role of 3D mammography with tomosynthesis in
breast screening, although early studies suggest that it may
improve speciﬁcity. They evaluated the effect of integrating
3D mammography on 158 consecutive recalls to assessment
in asymptomatic subjects and ﬁnally found out that their study
Fig. 8 Patient is 58 years old with history of right breast cancer post mastectomy. One year post therapy follow-up revealed contralateral
ductal carcinoma in situ (DCIS) solid and cribriform patterns with stromal microinvasion. (A) Left-sided FFDM and tomosynthesis MLO
and CC views show unremarkable ﬁndings. (B) Color Doppler US shows ill-deﬁned area of abnormal hypoechoic texture. Note small
feeding vessel targeting the lesion. According to the mammography the breast is BI-RADS 1 yet US displays BI-RADS 4a which is the
nearer category to the pathology results.
1060 S. Mansour et al.clearly demonstrates the capability of 3D tomosynthesis to
improve breast screening speciﬁcity and reduce recall rates.
Another experience (18) compared the image quality of
tomosynthesis with that of conventional mammography and
estimated the recall rate of screeningwhen tomosynthesis is used
in addition to mammography. There were 99 digital screening
recalls in 98 women. They stated that the image quality of tomo-
synthesis was equivalent (n= 51) or even superior (n= 37) to
diagnostic mammography in 89% (88/99). Finding type was sig-
niﬁcantly (P< 0.001) associated with equivalence. Approxi-
mately half – 52/99 (52%) – of the ﬁndings would not have
been recalled when digital screeningmammography was supple-
mented with tomosynthesis. When adjusting for confounding
conditions, the recall reductionwas 40% (37/92). The likelihood
of recall was also dependent on ﬁnding type (P= 0.004).
Our work limited by the fact that it was carried out in a
non-screening institute; most of the patients present with
well-established breast pathology and needed diagnostic mam-
mogram. Some of the cases had complaints regarding other
body system and were sent for check up, in other words sent
for Screening mammograms to exclude additional breast
disease. Such condition markedly limited recall/assessment
option.
From our experience we could recommend breast cancer
screening scheme as follows: First, start the screening imagewith
3D tomosynthesis ‘‘Combo-mode’’ imaging technique using the
CC views. If there was any impression of hidden pathology then
it is better to continue with 3D tomosynthesis technique. If no
abnormality was detected then instead do the MLO views with
the regular FFDM.Women with dense breasts, even with nega-
tive mammograms (i.e. BI-RADS 1) need additional breast
ultrasound examination to exclude malignancy.
5. Conclusion
Three-dimensional tomosynthesis signiﬁcantly enhances the
detection and characterization of breast lesions on digitalmammography especially in the context of dense breast paren-
chyma (ACR 3&4).
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